Most Men With Low-Risk Prostate Tumors Now Forgoing Treatment
Acceptance of active surveillance for low-risk prostate cancer hit a record high in 2021, although the US still lags internationally, new figures showed.
Medscape Medical News
source https://www.medscape.com/viewarticle/974009?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/974009?src=rss
Comments
Post a Comment